A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age.
Adolescent
Adult
Aged
Aged, 80 and over
Behavior
/ drug effects
Cannabis
Cognition
/ drug effects
Cross-Sectional Studies
Female
Humans
Male
Marijuana Use
/ epidemiology
Medical Marijuana
/ pharmacology
Middle Aged
Plant Extracts
/ pharmacology
Substance Withdrawal Syndrome
/ epidemiology
Young Adult
cognitive impairment
medical cannabis
neuropsychological effects
phytocannabinoids
Journal
Journal of alternative and complementary medicine (New York, N.Y.)
ISSN: 1557-7708
Titre abrégé: J Altern Complement Med
Pays: United States
ID NLM: 9508124
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
pubmed:
2
11
2018
medline:
16
4
2019
entrez:
2
11
2018
Statut:
ppublish
Résumé
There is a rapidly evolving legal and medical culture around cannabis, with corresponding changes in the demographics of users. For instance, the percentage of the aging population accessing cannabis is growing substantially, outpacing other age groups. The goals of this study were to describe the acute effects of cannabis, subjective experiences of withdrawal, and beliefs around the addictiveness of cannabis, as well as to determine whether these effects differ as a function of age or reason for use (medical vs. recreational use). It was hypothesized that medical users and younger users would report fewer adverse effects. Survey responses from 2905 cannabis users were analyzed. Hierarchical logistic regression analyses were used to compare group percentages after statistically controlling for confounding differences in their demographic and cannabis use characteristics. The most commonly endorsed acute effects were improved sleep, more calm/peaceful, desire to eat, more creative, and dry mouth; while the most commonly endorsed withdrawal symptoms were irritability, insomnia, and anxiety. Relative to recreational users, medical users were less likely to report undesirable acute effects but were more likely to report undesirable withdrawal symptoms. Older (50+) individuals reported fewer undesirable acute effects and withdrawal symptoms compared with younger users (18-29). Only 17% of the total sample reported believing that cannabis is addictive, and this did not vary as a function of reason for use. Older people and medical users appear to experience acute and withdrawal effects of cannabis differently than recreational and younger users, perhaps because these groups benefit more from the medicinal properties of cannabis. These data can provide descriptive information to help inform health care providers and potential consumers about effects of cannabis use.
Identifiants
pubmed: 30383388
doi: 10.1089/acm.2018.0319
pmc: PMC6437627
doi:
Substances chimiques
Medical Marijuana
0
Plant Extracts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
326-335Références
Arch Gen Psychiatry. 2001 Apr;58(4):322-8
pubmed: 11296091
Subst Abuse Treat Prev Policy. 2006 Jan 12;1:2
pubmed: 16722561
Mol Pharm. 2006 Nov-Dec;3(6):773-7
pubmed: 17140265
Addict Biol. 2007 Jun;12(2):158-66
pubmed: 17508987
Chem Biodivers. 2007 Aug;4(8):1729-43
pubmed: 17712817
Chem Biodivers. 2007 Aug;4(8):1770-804
pubmed: 17712819
Br J Pharmacol. 2008 Jan;153(2):199-215
pubmed: 17828291
Neuropsychopharmacology. 2008 Sep;33(10):2505-16
pubmed: 18185500
Subst Use Misuse. 2008;43(3-4):539-72; discussion 573-9, 585-7
pubmed: 18365950
J Neuroendocrinol. 2008 May;20 Suppl 1:10-4
pubmed: 18426493
J Psychopharmacol. 2011 Jan;25(1):121-30
pubmed: 20829306
Drug Alcohol Depend. 2011 May 1;115(1-2):120-30
pubmed: 21145178
Neuropsychopharmacology. 2011 May;36(6):1219-26
pubmed: 21307846
Neuroscience. 2011 May 5;181:1-17
pubmed: 21334423
N Engl J Med. 2011 Jun 9;364(23):2227-34
pubmed: 21651394
J Psychopharmacol. 2012 Jan;26(1):150-63
pubmed: 21693551
Br J Pharmacol. 2011 Aug;163(7):1344-64
pubmed: 21749363
Psychopharmacology (Berl). 2012 Mar;220(2):341-50
pubmed: 21975580
Exp Clin Psychopharmacol. 2012 Oct;20(5):420-429
pubmed: 22731735
Transl Psychiatry. 2012 Mar 20;2:e94
pubmed: 22832859
Epilepsia. 2014 Jun;55(6):791-802
pubmed: 24854329
CNS Neurol Disord Drug Targets. 2014;13(6):953-60
pubmed: 24923339
Schizophr Bull. 2015 Mar;41(2):391-9
pubmed: 25031222
Br J Pharmacol. 2015 Feb;172(3):737-53
pubmed: 25257544
Nat Rev Neurosci. 2015 Jan;16(1):30-42
pubmed: 25524120
J Anal Toxicol. 2015 May;39(4):251-61
pubmed: 25745105
Isr J Psychiatry Relat Sci. 2014;51(4):270-5
pubmed: 25841223
J Neuroimmune Pharmacol. 2015 Jun;10(2):255-67
pubmed: 25916739
Br J Pharmacol. 2015 Oct;172(20):4790-805
pubmed: 26218440
JAMA Psychiatry. 2015 Dec;72(12):1235-42
pubmed: 26502112
Drug Alcohol Depend. 2016 Feb 1;159:72-9
pubmed: 26686277
JAMA Intern Med. 2016 Mar;176(3):352-61
pubmed: 26831916
JAMA Psychiatry. 2016 Mar;73(3):292-7
pubmed: 26842658
Biol Psychiatry. 2016 Apr 1;79(7):557-67
pubmed: 26858214
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan 1;1(1):60-67
pubmed: 26858993
Addiction. 2017 Mar;112(3):516-525
pubmed: 27767235
Front Pharmacol. 2016 Oct 13;7:355
pubmed: 27790138
Front Pharmacol. 2016 Nov 08;7:422
pubmed: 27877130
Prog Chem Org Nat Prod. 2017;103:103-131
pubmed: 28120232
J Clin Pharm Ther. 2017 Jun;42(3):245-250
pubmed: 28191662
Addict Behav. 2017 Sep;72:1-7
pubmed: 28319813
Drug Alcohol Depend. 2017 Jun 1;175:67-76
pubmed: 28407543
Nat Med. 2017 Jun;23(6):782-787
pubmed: 28481360
J Pain Res. 2017 May 02;10:989-998
pubmed: 28496355
Drug Alcohol Depend. 2017 Aug 1;177:1-13
pubmed: 28549263
Front Pharmacol. 2017 May 11;8:259
pubmed: 28553229
N Engl J Med. 2017 Aug 17;377(7):699-700
pubmed: 28813226
Cannabis Cannabinoid Res. 2016 Jun 01;1(1):131-138
pubmed: 28861489
Cannabis Cannabinoid Res. 2016 Jul 01;1(1):166-175
pubmed: 28861492
Can J Public Health. 2017 Sep 14;108(3):e282-e287
pubmed: 28910251
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11229-11234
pubmed: 28973916
Clin Neuropharmacol. 2017 Nov/Dec;40(6):268-272
pubmed: 29059132
Life Sci. 2018 Jan 1;192:115-127
pubmed: 29169951
R I Med J (2013). 2018 Feb 2;101(1):13-14
pubmed: 29393303
Eur J Intern Med. 2018 Mar;49:44-50
pubmed: 29398248
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):741-753
pubmed: 29511052
Eur J Clin Invest. 2018 May;48(5):e12920
pubmed: 29574698
J Affect Disord. 2018 Aug 1;235:198-205
pubmed: 29656267
J Clin Oncol. 2018 Jul 1;36(19):1957-1962
pubmed: 29746226
Ann Intern Med. 2018 Sep 4;169(5):282-290
pubmed: 30039154
Neurosci Biobehav Rev. 2018 Oct;93:1-25
pubmed: 30056176
Epilepsy Behav. 2018 Oct;87:131-136
pubmed: 30100226